2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Nivolumab, IDO1 Inhibitor BMS-986205, Therapeutic Conventional Surgery - Lip, Oral Cavity Squamous Cell Carcinoma | Phase 2 | Terminated | Thomas Jefferson University | 65 | 2019-04-09 | 2026-10-19 |
| Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma Metformin Hydrochloride, Doxycycline, Metformin +Doxycycline - Larynx, LIP | Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 7 | 2017-04-03 | 2026-01-29 |
Laryngeal Diseases (2) · Carcinoma, Squamous Cell (1) · Lymphoid Interstitial Pneumonia (1) · Squamous Cell Carcinoma of Head and Neck (1)
Otorhinolaryngologic Diseases (2) · Respiratory Tract Diseases (2) · Carcinoma (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1)
Doxycycline (1) · Metformin (1) · Nivolumab (1) · linrodostat (1)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Thomas Jefferson University (1)
United States (2)
Adam Luginbuhl, MD (1) · Jennifer Johnson, MD, PhD (1)